Introduction {#s1}
============

Subjects with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) have an increased risk for type 2 diabetes \[[@R01]-[@R03]\]. Although more than half of the subjects who develop type 2 diabetes have IGT or IFG at baseline \[[@R04]\], prospective epidemiological studies have demonstrated that 30-40% of subjects have normal glucose tolerance (NGT) at baseline \[[@R01], [@R03], [@R05]\]. Studies in the general population have demonstrated that people with NGT whose postload plasma glucose returned to fasting plasma glucose (FPG) more slowly had greater insulin resistance, a lower early-phase insulin secretion and a higher risk of developing type 2 diabetes compared with people whose postload glucose concentration returned to baseline more quickly \[[@R06], [@R07]\]. We recently reported that young Japanese women whose post-breakfast glucose (PBG) never fell below FPG had lower meal-induced insulin responses (MIR) as compared to women whose PBG returned to levels below FPG \[[@R08]\].

Many of the metabolic abnormalities in subjects with IFG and/or IGT are thought to be secondary to obesity and increased insulin resistance \[[@R9]\]. Free fatty acids (FFAs) appear to link obesity not only to insulin resistance \[[@R10]\] but also to the deterioration in β-cell function \[[@R11]\]. Most obese subjects had elevated circulating FFA levels, which will inhibit insulin's antilipolytic action that will further increase FFA release into the circulation \[[@R12]\]. However, there are limited data in humans, in non-obese subjects in particular, on the association between circulating FFA levels and pancreatic β-cell function. Almost all experimental studies in humans used lipid infusions to raise circulating FFA levels \[[@R13]-[@R16]\]. In the present study, we sought to assess in young non-obese Japanese women 1) the relationship of the shape of glucose concentration curve during a standardized meal test to insulin resistance and insulin secretion and 2) whether variations in fasting and postprandial FFA are associated with changes, if any, in insulin resistance and insulin secretion. The relationship to birth weight was also studied because it has an inverse relationship with disorders of glucose regulation in adults \[[@R17]\].

Patients and Methods {#s2}
====================

We studied 35 Japanese women aged 21 - 24 years (17 female collegiate athletes and 18 untrained female students) as previously reported \[[@R08], [@R18]\]. Of 35 women, 32 provided weight at birth, and height and weight at 12 and 15 years old either through maternal and child health notebook records (issued by each municipal office). Thirty-one women provided data on family history of diabetes, which considered positive if they reported that one of siblings, parents or grandparents were on anti-diabetic drugs. Subjects who reported that they were in treatment for acute or chronic inflammatory diseases, endocrine, cardiovascular, hepatic, renal diseases, hormonal contraception and unusual dietary habits were excluded. Nobody reported to receive any medications or have regular supplements. The study was approved by the Ethics Committees of the University (No. 07-28) to be in accordance with the Helsinki declaration. All subjects gave written consent after the experimental procedure had been explained.

Athletes were students from the Department of Health and Sports Sciences and non-athletes from the Department of Food Sciences and Nutrition of the Mukogawa Women's University. They had been training regularly for 2 years or longer prior to the study, 5 h a day and 6 days a week and participated regularly in competitive events in their respective sport specialties. Athletes had regular training on the day before measurements. Although non-athletes were not engaged in any regular sport activity, they had 9,367 ± 1,971 steps/day (mean ± SD of a separate group of 77 non-athletes, who used a pedometer for consecutive 14 days and mean steps a day were calculated in each participant).

At 8:30 a.m. after a 12-h overnight fast, participants completed a standardized meal for breakfast and measurements of anthropometric indices and body composition as described later. Participants were asked to consume the entire meal within 15 min. Venous blood was drawn at baseline (0 min), 30, 60 and 120 min after the start of the meal for the measurement of plasma glucose (PG), serum insulin and FFA concentrations. PG was determined by the hexokinase/glucose-6-phosphate dehydrogenase method (inter-assay coefficient of variation (CV) \< 2%). Serum insulin was measured by an ELISA method with a narrow specificity excluding des-31, des-32 and intact proinsulin (interassay CV \< 6%). FFA was measured using enzymatic colorimetric method (Wako Chemicals, Tokyo, Japan). In fasted blood samples, the following were measured as previously reported \[[@R19]\]: serum cholesterol, triglycerides, HDL cholesterol, apolipoprotein AI and B-100 (apoAI and apoB, respectively), adiponectin, leptin and high-sensitivity C-reactive protein (hsCRP).

MIR was calculated as the increment in serum insulin (Δinsulin30) divided by the increment in PG (Δglucose30) during the first 30 min of the meal test and expressed in µU/mg. The area under the concentration curve (AUC) of PG, serum insulin and FFA was calculated with the trapezoidal method (AUCg, AUCi and AUCffa, respectively). Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as a more reflective surrogate of hepatic insulin resistance \[[@R20]\]. The adipose insulin resistance (Adipo-IR) was calculated as a product of fasting insulin and FFA concentrations \[[@R21]\].

The standardized test meal was developed by the Japanese Diabetes Society to assess both postprandial hyperglycemia and hyperlipidemia \[[@R22]\]. This meal was composed as a breakfast meal (total energy 450 kcal) and provided 33.3% of calories from fat (16.7 g), 51.4% from carbohydrates (57.8 g) and 15.3% from protein (17.2 g). The test meal contained more fat than a typical Japanese breakfast (20-25%) but comparable energy content (median: 423 kcal).

Lean mass, fat mass, and bone mineral mass for arms, legs, trunk and the total body were quantified by whole-body DXA (Hologic QDR-2000, software version 7.20D, Waltham, MA) as previously reported \[[@R19]\]. The leg region included the entire hip, thigh and leg. General adiposity was assessed using height-adjusted and weight-adjusted body fat. The former, fat mass index (FMI), was calculated as body fat mass in kg divided by height in meter squared and the latter, percent body fat, was calculated as body fat mass in kg divided by body weight in kg × 100. Abdominal fat accumulation was assessed by the ratio of trunk to leg fat \[[@R23]\].

Statistical analysis {#s2a}
--------------------

Data were presented as mean ± SD unless otherwise stated. Due to deviation from normal distribution, HOMA-IR and hsCRP were logarithmically transformed for analyses. Young women were divided into four groups based on the relationship between PBG and FPG. Group A included two women whose PBG returned to levels below FPG at 30 min. Groups B (n = 15) and C (n = 11) included women whose PBG returned to levels below FPG at 60 and 120 min, respectively and group D included seven women whose PBG never fell below FPG. The association of continuous variables with groups A through D and P values for trend were derived using Jonckheeree-Terpstra test. In categorical data analysis, Cochran-Armitage trend analysis was used. ANOVA and then Bonferroni's multiple comparison procedures were used when appropriate. A two-tailed P \< 0.05 was considered statistically significant. All calculations were performed with SPSS system 15.0 (SPSS Inc., Chicago, IL, USA).

Results {#s3}
=======

As previously reported \[[@R08], [@R18]\], participants were normal weight, normoglycemic, normolipidemic and insulin-sensitive as demonstrated by mean HOMA-IR \< 1.0 ([Table 1](#T1){ref-type="table"}). Birth weight \< 2,500 g and positive family history of diabetes were reported in 6.3% (2/32) and 32.3% (10/32), respectively.

###### Anthropometric, Laboratory and Clinical Characteristics of the Four Study Groups Based on the Time (30, 60 and 120 Min or Never) That the Plasma Glucose (PG) Concentration During the OGTT Declined Below the Fasting PG Concentration

  Group                            A             B             C             D             \*     \#
  -------------------------------- ------------- ------------- ------------- ------------- ------ ------
  BMI (kg/m^2^)                    23.3 ± 6.2    22.3 ± 2.4    21.3 ± 2.3    21.3 ± 1.5    0.34   0.67
  FMI (kg/m^2^)                    7.40 ± 5.61   6.14 ± 2.06   5.22 ± 1.58   5.42 ± 1.32   0.44   0.70
  Waist circumeference (cm)        76.1 ± 10.0   74.1 ± 7.0    74.4 ± 6.3    71.4 ± 4.2    0.60   0.72
  Percentage body fat (%)          30.0 ± 16.7   27.4 ± 6.7    24.5 ± 5.5    25.8 ± 6.0    0.37   0.63
  Trunk/leg fat ratio              0.96 ± 0.03   1.27 ± 0.25   1.19 ± 0.32   1.24 ± 0.16   0.64   0.42
  Cholesterol (mg/dL)              205 ± 8       182 ± 23      173 ± 22      172 ± 22      0.10   0.25
  Triglycerides (mg/dL)            59 ± 20       58 ± 16       52 ± 21       52 ± 22       0.26   0.85
  HDL cholesterol (mg/dL)          83 ± 11       76 ± 12       72 ± 12       68 ± 10       0.13   0.33
  Apolipoprotein A1 (mg/dL)        165 ± 15      164 ± 15      157 ± 15      151 ± 11      0.02   0.24
  Apolipoprotein B (mg/dL)         79 ± 1        67 ± 13       65 ± 17       64 ± 11       0.27   0.59
  Leptin (ng/mL)                   10.1 ± 5.4    8.3 ± 5.2     5.0 ± 2.0     6.5 ± 4.1     0.10   0.19
  Adiponectin (µg/mL)              17.1 ± 5.7    10.2 ± 3.9    12.0 ± 5.5    10.5 ± 2.7    0.92   0.20
  hsCRP (µg/dL)                    13 ± 6        62 ± 128      28 ± 47       30 ± 55       0.14   0.74
  Athletes (n, %)                  1, 50         8, 53.3       4, 36.4       4, 57.1       0.62   0.80
  Positive family history (n, %)   0/2, 0.0      6/13, 46.2    3/9, 33.3     1/7, 14.3     0.37   0.37
  Birth weight (g)                 3,355 ± 78    3,090 ± 397   3,252 ± 452   2,960 ± 529   0.38   0.80

Data are expressed as mean ± SD. \*P values by Jonckheeree-Terpstra trend test. ^\#^P values by ANOVA. FMI: fat mass index; hsCRP: high-sensitivity C-reactive protein.

There was no difference in BMI, waist circumference, FMI, percentage body fat, trunk/leg fat ratio, serum adiponectin, leptin and hsCRP among the four groups ([Table 1](#T1){ref-type="table"}). Although FPG, fasting insulin and hence HOMA-IR did not differ, fasting FFA was lower in groups A and B versus C and D ([Figs. 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). However, the difference in Adipo-IR, which showed a pattern similar to fasting FFA, was not significant ([Table 2](#T2){ref-type="table"}). There was also no difference in birth weight, the percentage of athletes and that of women with positive family history of diabetes ([Table 1](#T1){ref-type="table"}).

![Mean plasma glucose, insulin and free fatty acid (FFA) concentrations based on the time (30, 60 and 120 min or never: groups A through D) that the plasma glucose concentration during the meal test declined below the fasting plasma glucose concentration. \*: the difference is significant at P \< 0.05 or less by ANOVA and Bonferroni's multiple comparison procedure: 30-min glucose, A versus C and D; 60-min glucose and fasting FFA, A and B versus C and D; 120-min glucose, A, B and C versus D; 30-min FFA, A versus C. Group A: blue lines; B: green lines; C: yellow lines; D: red lines.](jocmr-10-822-g001){#F1}

![Fasting free fatty acids (FFAs), areas under the concentration curves of glucose, insulin and FFA (Glucose-AUC, Insulin-AUC and FFA-AUC, respectively) in groups A through D. Group A: blue columns; B: green columns; C: yellow columns; D: red columns. Data are expressed as mean ± SD. P values for trend derived using Jonckheeree-Terpstra test were shown.](jocmr-10-822-g002){#F2}

###### Responses of Glucose, Insulin and Free Fatty Acids to a Standardized Test Meal of the Four Study Groups Based on the Time (30, 60 and 120 Min or Never) That the Plasma Glucose (PG) Concentration During the OGTT Declined Below the Fasting PG Concentration

  Group                     A             B             C             D             \*      \#      
  ------------------------- ------------- ------------- ------------- ------------- ------- ------- ------------
  Fasting PG (mg/dL)        86 ± 8        85 ± 5        83 ± 4        82 ± 4        0.174   0.532   
  30-min PG (mg/dL)         80 ± 11       103 ± 14      111 ± 13      111 ± 9       0.019   0.017   b, c
  60-min PG (mg/dL)         61 ± 12       71 ± 10       101 ± 11      95 ± 16       0.000   0.000   b, c, d, e
  120-min PG (mg/dL)        63 ± 2        72 ± 8        70 ± 8        90 ± 5        0.002   0.000   c, e, f
  Fasting insulin (µU/mL)   2.0 ± 1.9     4.4 ± 2.6     3.2 ± 1.2     3.3 ± 1.2     0.639   0.480   
  30-min insulin (µU/mL)    38 ± 20       40 ± 21       26 ± 13       29 ± 16       0.101   0.230   
  60-min insulin (µU/mL)    17 ± 9        28 ± 19       32 ± 16       22 ± 14       0.564   0.531   
  120-min insulin (µU/mL)   8 ± 3         14 ± 9        10 ± 7        15 ± 9        0.693   0.552   
  Δglucose30 (mg/dL)        -6 ± 4        19 ± 16       28 ± 12       28 ± 7        0.007   0.009   b, c
  Δinsulin30 (µU/mL)        36 ± 22       35 ± 19       22 ± 12       26 ± 15       0.098   0.239   
  HOMA-IR                   0.4 ± 0.4     0.9 ± 0.6     0.7 ± 0.2     0.7 ± 0.2     0.616   0.430   
  MIR                       \-            4.2 ± 4.4     1.0 ± 0.6     0.9 ± 0.4     0.030   0.031   d
  Glucose-AUC               138 ± 16      162 ± 13      187 ± 9       192 ± 14      0.000   0.000   b, c, d, e
  Insulin-AUC               36 ± 18       49 ± 27       43 ± 21       40 ± 21       0.638   0.779   
  Adipo-IR                  0.53 ± 0.56   1.66 ± 0.98   1.85 ± 1.11   1.90 ± 0.76   0.111   0.343   
  Fasting FFA (mEq/L)       0.26 ± 0.04   0.39 ± 0.13   0.55 ± 0.16   0.57 ± 0.09   0.000   0.002   b, c, d, e
  30-min FFA (mEq/L)        0.18 ± 0.03   0.32 ± 0.11   0.40 ± 0.10   0.39 ± 0.07   0.008   0.022   b
  60-min FFA (mEq/L)        0.17 ± 0.05   0.23 ± 0.09   0.25 ± 0.06   0.23 ± 0.03   0.267   0.437   
  120-min FFA (mEq/L)       0.23 ± 0.11   0.23 ± 0.06   0.23 ± 0.07   0.22 ± 0.03   0.749   0.980   
  FFA-AUC                   0.39 ± 0.10   0.55 ± 0.15   0.64 ± 0.08   0.62 ± 0.08   0.031   0.033   

Data are expressed as mean ± SD. PG: plasma glucose; Δglucose30 and Δinsulin30: the increment in PG and serum insulin during the first 30 min of the meal test; HOMA-IR: homeostasis model assessment of insulin resistance; MIR: meal-induced insulin response; AUC: the area under the concentration curve; Adipo-IR: adipose insulin resistance; FFA: free fatty acid. \*P values by Jonckheeree-Terpstra trend test. ^\#^P values by ANOVA. a, b and c: group A versus B, C and D, respectively; d and e: group B versus C and D, respectively; f: group C versus D by Bonferroni's multiple comparison procedures.

Despite clearly separated glucose and FFA concentration curves after meal ingestion ([Fig. 1](#F1){ref-type="fig"} and [Table 2](#T2){ref-type="table"}), post-breakfast insulinemia among the four groups were similar. As summarized in [Figure 2](#F2){ref-type="fig"}, not only fasting FFA and AUCffa but also AUCg were the lowest in group A, increased linearly from group B to C, and plateaued in group D whereas AUCi did not differ. Incremental changes in Δglucose30 ([Fig. 3](#F3){ref-type="fig"}) from groups A through D were quite similar to those in fasting FFA and AUCffa, whereas Δinsulin30 did not differ among four groups. Although not depicted in [Figure 3](#F3){ref-type="fig"} because of negative values, MIR might be the highest in group A, and decreased from group B to C and D.

![Incremental glucose (Δglucose30) and insulin (Δinsulin30) concentrations during the first 30 min of meal tests, meal-induced responses and serum apolipoprotein AI in groups A through D. Group A: blue columns; B: green columns; C: yellow columns; D: red columns. Data are expressed as mean ± SD. P values for trend derived using Jonckheeree-Terpstra test were shown.](jocmr-10-822-g003){#F3}

There was a trend towards a decrease in apoAI from group A through group D ([Fig. 3](#F3){ref-type="fig"} and [Table 1](#T1){ref-type="table"}), although serum concentrations of HDL cholesterol, triglyceride and apoB did not differ ([Table 1](#T1){ref-type="table"}).

Discussion {#s4}
==========

The main finding of the present study is that even in healthy, normal weight Japanese women in early adult life, progressive increases in fasting FFA and AUCffa were associated not only with progressive increases in muscle insulin resistance but also with progressives decreases in MIR. These associations were not related to general and central adiposity (FMI and trunk/leg fat ratio, respectively), birth weight, serum concentrations of adiponectin and hsCRP, family history of diabetes and the presence of endurance training. It is noteworthy that these findings were observed in a young, normal weight population in which confounding factors are so scarce \[[@R08], [@R18], [@R19]\].

Although FFA is well known to be a key factor in the development of insulin resistance in obese subjects \[[@R10]\], there are limited data in non-obese humans on the association between normal variations in FFA levels and pancreatic β-cell function. Elevated fasting FFA was associated with deterioration of acute insulin response determined using intravenous GTT in Pima Indians with IGT but not NGT \[[@R24]\]. In the San Antonio Metabolism study, the progressive decline in insulin secretion in individuals with NGT is associated with a progressive increase in fasting FFA and Adipo-IR \[[@R25]\]. Because fasting FFA represents only a short period of time during each day, other time points, such as postprandial FFA, may be more relevant. In the present study, normal variations in postprandial FFA assessed by AUCffa as well as fasting FFA levels were associated with differences in insulin secretion and insulin resistance in young healthy non-obese women with normal glucose tolerance. The current results may be consistent with prospective studies that showed a significant association between the fasting plasma FFA concentration or Adipo-IR and incidence of type 2 diabetes \[[@R25], [@R26]\]. Failure to detect statistical significance in Adipo-IR may be due to small sample size in the present study.

An increase in AUCg from groups A through D in the presence of comparable AUCi may suggest increased muscle insulin resistance from groups A through D. This may be in line with the previous observations in the general population \[[@R06], [@R07]\] that those whose post-load PG returned to FPG more slowly had a lower glucose-induced insulin secretion and increased muscle insulin resistance as compared with those whose postload PG returned to FPG more quickly.

People with NGT whose postload PG returned to FPG more slowly had greater BMI, waist circumference, serum triglycerides, FPG and serum insulin, and lower HDL cholesterol compared with people whose postload PG returned to baseline more quickly \[[@R06]\]. Although young normal weight Japanese women did not have anthropometric and metabolic characteristics of insulin resistance, they had decreased apoAI, a major apolipoprotein of HDL, which has been shown to increase glucose-stimulated insulin secretion and insulin-independent peripheral tissue glucose uptake, leading to increased heart and skeletal muscle glucose disposal \[[@R27]\].

An increase in AUCg during a standardized meal test was not related to serum concentrations of adiponectin, leptin and hsCRP, birth weight, the percentage of athletes and that of women with positive family history of diabetes.

This study has several strengths, including a homogeneous study population with scarce confounding factors, and accurate and reliable measures of body composition by dual energy X-ray absorptiometry (DXA). The main limitation of our study is small sample size. DXA does not allow separate quantification of visceral fat and subcutaneous fat in the trunk. However, the association of trunk fat with HOMA-insulin resistance was comparable to that of visceral adipose tissue accumulation by computed tomography \[[@R28]\]. The cross-sectional design of the present study complicates the drawing of causal inferences, and a single measurement of biochemical variables may be susceptible to short-term variation, which would bias the results toward the null. We used several surrogates in the present study, which may be less accurate.

Conclusions {#s4a}
-----------

Young women whose PBG returned to FPG more slowly had higher fasting and post-breakfast FFA, greater muscle insulin resistance and lower MIR compared with young women whose PBG returned to baseline more quickly. These associations were not related to general and abdominal adiposity, adiponectin and inflammation.
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Adipo-IR

:   adipose insulin resistance

apoAI and apoB

:   apolipoprotein AI and B-100, respectively

AUC

:   area under the concentration curve

CV

:   coefficient of variation

Δglucose30 and Δinsulin30

:   the increment in glucose and insulin during the first 30 min of the meal test, respectively

FFA

:   free fatty acid

FMI

:   fat mass index

FPG

:   fasting plasma glucose

hsCRP

:   high-sensitivity C-reactive protein

HOMA-IR

:   homeostasis model assessment of insulin resistance

IGT

:   impaired glucose tolerance

IFG

:   impaired fasting glucose

MIR

:   meal-induced insulin response

NGT

:   normal glucose tolerance

PBG

:   post-breakfast glucose

PG

:   plasma glucose
